0000950123-20-011698.txt : 20201113
0000950123-20-011698.hdr.sgml : 20201113
20201113115451
ACCESSION NUMBER: 0000950123-20-011698
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201113
DATE AS OF CHANGE: 20201113
EFFECTIVENESS DATE: 20201113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM Oncology Impact Management LP
CENTRAL INDEX KEY: 0001687078
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 201310079
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001687078
XXXXXXXX
09-30-2020
09-30-2020
false
MPM ONCOLOGY IMPACT MANAGEMENT LP
450 KENDALL STREET
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-20107
N
Ansbert Gadicke
Managing Director
(617) 425-9200
/s/Ansbert Gadicke
Cambridge
MA
11-12-2020
0
12
408815
false
INFORMATION TABLE
2
1810.xml
INFORMATION TABLE FOR FORM 13F
ADC Therapeutics, Inc.
Common
H0036K147
17803
539648
SH
SOLE
539648
0
0
Autolus Therapeutics Limited
Common
05280R100
463
39740
SH
SOLE
39740
0
0
Epizyme, Inc.
Common
29428V104
27815
2331534
SH
SOLE
2331534
0
0
G1 Therapeutics, Inc.
Common
3621LQ109
16445
1423794
SH
SOLE
1423794
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
66234
3898422
SH
SOLE
3898422
0
0
iTeos Therapeutics, Inc.
Common
46565G104
58112
2355557
SH
SOLE
2355557
0
0
MEI Pharma, Inc.
Common
552798202
31630
10137859
SH
SOLE
10137859
0
0
Merus N.V.
Common
N5749R100
8411
700879
SH
SOLE
700879
0
0
Repare Therapeutics, Inc.
Common
760273102
73489
2388337
SH
SOLE
2388337
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
68498
3370982
SH
SOLE
3370982
0
0
Turning Point Therapeutics, Inc.
Common
90041T108
26967
308686
SH
SOLE
308686
0
0
YmAbs Therapeutics, Inc.
Common
984241109
12949
337291
SH
SOLE
337291
0
0